Hansa Biopharma AB
Developing innovative immunomodulating therapies for rare immunologic diseases.
Översikt
- 100–199
- Anställda
- 50–100milj SEK
- Omsättning
- 2007
- Grundat
Nyckelbeslutsfattare
Hitto Kaufmann
Chief Scientific & Technology Officer
Richard Philipson
Chief Medical Officer
Brian Gorman
Chief Legal Officer and Corporate Secretary
Evan Ballantyne
Chief Financial Officer
+17 fler kontakter i Funnelfeedr
Beskrivning
Hansa Biopharma is a science-led biopharmaceutical company dedicated to empowering people living with rare immunologic diseases. They focus on developing innovative immunomodulating therapies designed to transform patient lives. The company leverages proprietary antibody-cleaving enzyme technology,...